November 2026 Letter to the Editor
Oncology Nursing Forum · 09.11.2026 · 53 (6)
DOI: 10.1188/26.onf.e26535394 ↗Kurz gefasst
Leserbrief in der Zeitschrift Oncology Nursing Forum, online erschienen am 09.11.2026. Verfasst von Mahsa Zarghami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mahsa Zarghami. Hauptthemen laut MEDLINE: Oncology Nursing, Antineoplastic Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
POLICY FOR LETTERS TO THE EDITOR: Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questions, criticizes, or responds to a previously published Oncology Nursing Forum article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Send letters to ONFEditor@ons.org.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mahsa Zarghami.
- Janine Overcash.
- Karen DiValerio Gibbs.
Zitieren
APA
Zarghami, M., Overcash, J., & DiValerio Gibbs, K. (2026). November 2026 Letter to the Editor. Oncology Nursing Forum, 53(6). https://doi.org/10.1188/26.onf.e26535394
Vancouver
Zarghami M, Overcash J, DiValerio Gibbs K. November 2026 Letter to the Editor. Oncology Nursing Forum. 2026;53(6). doi:10.1188/26.onf.e26535394
BibTeX
@article{Zarghami2026,
author = {Zarghami, Mahsa and Overcash, Janine and DiValerio Gibbs, Karen},
title = {November 2026 Letter to the Editor},
journal = {Oncology Nursing Forum},
year = {2026},
volume = {53},
number = {6},
doi = {10.1188/26.onf.e26535394}
}
EUVIMED